vs
EOG资源(GURE)与Spero Therapeutics, Inc.(SPRO)财务数据对比。点击上方公司名可切换其他公司
Spero Therapeutics, Inc.的季度营收约是EOG资源的1.4倍($12.6M vs $9.0M),Spero Therapeutics, Inc.净利率更高(250.7% vs -394.3%,领先645.0%),Spero Therapeutics, Inc.同比增速更快(24080.8% vs 303.4%),过去两年Spero Therapeutics, Inc.的营收复合增速更高(847.7% vs -37.1%)
EOG资源是一家美国能源企业,主营业务为油气勘探开发。公司注册于特拉华州,总部位于德克萨斯州休斯顿的传统广场大厦,是美国本土重要的独立油气生产商之一。
GURE vs SPRO — 直观对比
营收规模更大
SPRO
是对方的1.4倍
$9.0M
营收增速更快
SPRO
高出23777.4%
303.4%
净利率更高
SPRO
高出645.0%
-394.3%
两年增速更快
SPRO
近两年复合增速
-37.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $9.0M | $12.6M |
| 净利润 | $-35.7M | $31.5M |
| 毛利率 | — | — |
| 营业利润率 | -3.7% | — |
| 净利率 | -394.3% | 250.7% |
| 营收同比 | 303.4% | 24080.8% |
| 净利润同比 | -921.1% | 250.9% |
| 每股收益(稀释后) | — | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GURE
SPRO
| Q4 25 | — | $12.6M | ||
| Q3 25 | $9.0M | $0 | ||
| Q2 25 | $8.3M | $0 | ||
| Q1 25 | — | $12.0K | ||
| Q4 24 | — | $52.0K | ||
| Q3 24 | — | $65.0K | ||
| Q2 24 | — | $114.0K | ||
| Q1 24 | — | $140.0K |
净利润
GURE
SPRO
| Q4 25 | — | $31.5M | ||
| Q3 25 | $-35.7M | $-7.4M | ||
| Q2 25 | $-773.8K | $-1.7M | ||
| Q1 25 | — | $-13.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-17.1M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | — | $-12.7M |
营业利润率
GURE
SPRO
| Q4 25 | — | — | ||
| Q3 25 | -3.7% | — | ||
| Q2 25 | -9.0% | — | ||
| Q1 25 | — | -122758.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -28604.6% | ||
| Q2 24 | — | -16720.2% | ||
| Q1 24 | — | -9987.1% |
净利率
GURE
SPRO
| Q4 25 | — | 250.7% | ||
| Q3 25 | -394.3% | — | ||
| Q2 25 | -9.3% | — | ||
| Q1 25 | — | -115550.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -26380.0% | ||
| Q2 24 | — | -15668.4% | ||
| Q1 24 | — | -9049.3% |
每股收益(稀释后)
GURE
SPRO
| Q4 25 | — | $0.56 | ||
| Q3 25 | — | $-0.13 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.25 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.32 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $40.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $107.5M | $59.0M |
| 总资产 | $131.9M | $68.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
GURE
SPRO
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
股东权益
GURE
SPRO
| Q4 25 | — | $59.0M | ||
| Q3 25 | $107.5M | $26.5M | ||
| Q2 25 | $142.2M | $32.8M | ||
| Q1 25 | — | $33.8M | ||
| Q4 24 | — | $46.1M | ||
| Q3 24 | — | $65.5M | ||
| Q2 24 | — | $80.5M | ||
| Q1 24 | — | $96.2M |
总资产
GURE
SPRO
| Q4 25 | — | $68.9M | ||
| Q3 25 | $131.9M | $54.2M | ||
| Q2 25 | $164.6M | $62.1M | ||
| Q1 25 | — | $77.7M | ||
| Q4 24 | — | $110.5M | ||
| Q3 24 | — | $135.2M | ||
| Q2 24 | — | $149.9M | ||
| Q1 24 | — | $167.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $6.7M | $-8.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
GURE
SPRO
| Q4 25 | — | $-8.4M | ||
| Q3 25 | $6.7M | $17.4M | ||
| Q2 25 | $-559.3K | $-17.7M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $-23.4M | ||
| Q3 24 | — | $12.8M | ||
| Q2 24 | — | $-18.7M | ||
| Q1 24 | — | $5.9M |
现金转化率
GURE
SPRO
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GURE
| Bromine | $8.1M | 89% |
| Shandong Shouguang Shenrunfa Marine Chemical Company Limited | $1.4M | 15% |
SPRO
暂无分部数据